Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors
J.P. Peyrat, A Demaille(Centre Oscar Lambret), Jean Djiane(Inserm), Hélène Jammes(Maternité Port Royal), B Hecquet(Institut für Gießereitechnik), P Vennin(Centre Oscar Lambret), R. Beuscart, Jean Louis Lefèbvre(Centre Oscar Lambret), Jacques Bonneterre(Université Lille Nord de France)
The Journal of Steroid Biochemistry and Molecular Biology
December 1, 1990
Cited by 49
Related Papers
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
|Journal of Clinical Oncology|2000|840
p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies
|Blood|1994|581
Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study
|Journal of Clinical Oncology|2013|418
Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
|JNCI Journal of the National Cancer Institute|2009|282